![](/img/cover-not-exists.png)
Use of erlotinib in patients selected using clinical criteria in the 2nd and 3rd line treatment of non-small cell lung cancer (NSCLC)
Stavridi, F., Eestila, S., Merchant, S., Cane, P., Spicer, J.Volume:
63
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(09)70015-7
Date:
January, 2009
File:
PDF, 66 KB
english, 2009